Philly.com (blog) |
Mylan shares jump after FDA lays out guidelines for asthma generic
MarketWatch (blog) Shares of Mylan Inc. jumped nearly 5% in mid-afternoon trades on Tuesday after it became clear the U.S. Food and Drug Administration's guidelines on generic forms of GlaxoSmithKline's asthma medication Advair would work in favor of Mylan, considered a … FDA issues generic guidance on GSK's top-selling asthma drug, Advair GlaxoSmithKline Shares Fall After Advair Setback GSK shares hit as Advair generic threat grows in US |
View full post on asthma – Google News